Saving Lives
The Angels Initiative celebrates stroke nurses, saving lives “one grandpa at a time”. Click here to learn more and to find out more information.
Search
Benefits of Pradaxa®
Here you can find a discussion of the benefits offered by Pradaxa® for stroke prevention in patients with atrial fibrillation. Click here to learn more.
Patient voices Ulrichs story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Ulrich's story.
Patient voices Eves story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Eve's story.
Driving Innovation through Diversity & Inclusion
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Diabetes
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Learn more here.
A Unique Bond: friends in need
After suffering from a stroke, Phil’s connection with Valle helped change his life
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India
Boehringer Ingelheim launches additional heart failure indication for Jardiance® (empagliflozin) in India. Click here to find out and learn more.
Heart Diseases
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.
Professor Gregory Lip introduces the GLORIA™-AF Registry
In this video, Prof. Gregory Lip introduces the GLORIA™-AF Registry Program. Click here to watch the video and to learn more about the program.
COVID-19 Volunteering in a Food Bank to help the new poors
Massimo Grasso volunteered 10 days in a national organisation in Italy supporting charities working for food distribution to families in need.
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
About Us
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here to learn and find out more about us.
More Health: For People & Animals
Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities.
EMPRISE real-world study design
World Heart Day 2021
The heart is one of the things with the potential to unite all of us as people. Click here to read patient stories about their heartbeat moment.
COVID-19 General Q&A
Here we provide a list of questions and answers about COVID-19, including what it is, how it spreads, and more. Click here to find out more.
Telling my story AF and DVT PE Patient Voices
Telling My Story is a video series featuring stories from across the world from patients with AF, DVT, and PE. Click here to hear their stories.
Boehringer Ingelheim - Value Through Innovation
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here to learn more.
COVID-19 Joining forces against COVID-19
While the challenges posed by the COVID-19 pandemic are massive, so are the good examples of corporate citizenship arising all over the world. Learn more.
3 things you should know about avian influenza
Poultry farming communities across the globe are grappling once again with avian influenza. Click here to find out three things you should know about it.
Patient voices Augustos story
Hear from patients and families on how atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE) have affected their lives.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
Harold Heart and Dorothy Diabetes
People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes. Click here to learn more.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.